-
Advances in the Prevention and Treatment of Radiation Skin Injury: Mechanisms, Pharmacological Interventions, and Applications of Novel Dressings
21 Jan 2026 08:13 GMT
… of Drugs for RSI Treatment
Limitations of Pharmacological Treatment
Despite … 93 With advancements in biotechnology and material science, … I/II clinical trials. The translation from … advancements in skin regenerative medicine. Pharmaceutics. 2022;14:1574. …
-
Kiniksa Pharmaceuticals Provides Corporate Update
12 Jan 2026 12:30 GMT
… (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA … Food and Drug Administration (FDA) for the treatment of recurrent … call your doctor right away. Treatment with ARCALYST … as Kineret® (anakinra), or medicines that block tumor …
-
UAE doctors warn childhood arthritis can be fatal after saving Emirati boy’s life
05 Jan 2026 19:18 GMT
Arthritis is often seen as a condition of old age, but doctors in … initially received anakinra, a medication requiring daily injections — a challenging treatment for a … doctors later transitioned him to tocilizumab, a targeted biologic therapy. His treatment …
-
Trained Immunity: RoadMap for drug discovery and development
23 Dec 2025 17:17 GMT
… days of continuous medication and restimulated with C … Wheezing Attacks)
(b) Trials investigating modulation of Trained … (s)
Dexamethasone
Tocilizumab
Anakinra
Primary Outcome
Plasma TNF … between baseline and atorvastatin treatment cycles. Timeframe: 16 …
-
Fred Hutch at ASH: Expanding CAR-T access, AML treatment strategies, climate and cancer -- and ASH lifetime achievement award
03 Dec 2025 02:25 GMT
… also treated with anakinra, a drug that blocks inflammation. … events and delayed treatment initiation among patients … commercialization.
The clinical trials referenced above involve investigational … care sites that provide medical oncology, infusion, radiation …
-
Advancing Gouty Arthritis Research: The Clinical Value of Complete Blood Cell Count Ratios and Immune-Inflammatory Interactions
26 Nov 2025 11:22 GMT
… GA include urate-lowering drugs, colchicine, and nonsteroidal … 0.05). Following standardized treatment, AG patients experienced significant … risk assessment and precision medicine.75,79 However, several … and safety of anakinra in gouty arthritis: a case series …
-
<![CDATA[AVTX-009 Completes Enrollment in HS Phase 2 Trial]]>
29 Oct 2025 22:19 GMT
… during a 16-week treatment phase. The trial’s primary endpoint is … IL-1 blockade (e.g., anakinra) have demonstrated variable results, possibly … monitoring developments from ongoing clinical trials such as LOTUS.
References
Avalo …
-
Kiniksa Pharmaceuticals Reports Third Quarter 2025 Financial Results and Recent Portfolio Execution
28 Oct 2025 11:30 GMT
… Drug Administration (FDA) granted Orphan Drug Designation to KPL-387 for the treatment … doctor right away. Treatment … (anakinra), or medicines that …
KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC
SELECTED CONSOLIDATED BALANCE …
-
<![CDATA[Real-World Studies Reinforce Axi-Cel and Liso-Cel as Effective LBCL Treatments ]]>
23 Oct 2025 03:23 GMT
… FDA approvals of axi-cel and liso-cel affected the LBCL treatment … 3 ZUMA-7 trial [NCT03391466] … treatment for these complications, including tocilizumab [Actemra], steroids, and anakinra … [Kineret], similar to what was observed in the [clinical trials …
-
RINVOQ® Demonstrated Superiority Versus HUMIRA® for Primary Endpoint in a Head-to-Head Study in Rheumatoid Arthritis Patients Who Have Failed First TNF Inhibitor
20 Oct 2025 16:43 GMT
… of prescription drugs to the FDA. Visit www.fda.gov… with ORENCIA® (abatacept), KINERET® (anakinra), REMICADE® (infliximab), ENBREL® ( …
Call your doctor or get medical care right away … Guideline for the Treatment of Rheumatoid Arthritis. Arthritis Care Res ( …
About
© 1995-2026